MEDQUIST IP LLC – Trademark Portfolio
Entity Type: 16
MEDQUIST IP LLC has 35 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include CLARITY. The portfolio includes 1 registered trademark. Filings span 4 Nice Classification classes, led by Class 9 (Computers & Electronics) and Class 42 (Computer & Scientific). This trademark owner is based in Franklin, TN.
5000 Meridian Blvd., St. 200
Franklin, TN 37067
Showing of trademarks Trademarks
Trademark Classifications
MEDQUIST IP LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does MEDQUIST IP LLC have?
MEDQUIST IP LLC has 35 U.S. trademarks filed with the USPTO. Of these, 1 registered, 15 abandoned, 19 cancelled.
What trademark classes does MEDQUIST IP LLC file in?
MEDQUIST IP LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are MEDQUIST IP LLC's most well-known trademarks?
MEDQUIST IP LLC's registered trademark portfolio includes well-known marks such as CLARITY. These are among 1 currently registered trademark in the portfolio.
What is MEDQUIST IP LLC's trademark registration success rate?
MEDQUIST IP LLC has a 3% trademark registration rate, with 1 out of 35 resolved applications resulting in successful registration. Currently, 0 applications are pending review.